These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3304909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody.
    Negishi K, Kawazu S, Ishii J, Kanazawa Y.
    J Clin Lab Immunol; 1986 Apr; 19(4):155-9. PubMed ID: 3014151
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Analysis of islet cell surface antigen reactions with islet cell surface antibodies (ICSA)].
    Hakamata M, Itoh M.
    Nihon Naibunpi Gakkai Zasshi; 1990 Jul 20; 66(7):700-14. PubMed ID: 2204556
    [Abstract] [Full Text] [Related]

  • 5. Complement activation pathways associated with islet cell surface antibody (ICSA) derived from child patients with insulin-dependent diabetes mellitus (IDDM).
    Okada S, Ichiki K, Sato K, Tanokuchi S, Ishii K, Hamada H, Ota Z.
    Acta Med Okayama; 1991 Jun 20; 45(3):185-6. PubMed ID: 1909828
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B, Michaelis D, Hildmann W, Richter KV, Kohnert KD.
    Diabetes Res; 1987 Feb 20; 4(2):73-7. PubMed ID: 3034475
    [Abstract] [Full Text] [Related]

  • 7. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.
    Kohnert KD, Hehmke B, Fält K, Ziegler M.
    Biomed Biochim Acta; 1984 Feb 20; 43(5):663-73. PubMed ID: 6206850
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus.
    Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL.
    N Engl J Med; 1980 Dec 25; 303(26):1493-8. PubMed ID: 7001237
    [Abstract] [Full Text] [Related]

  • 9. Studies on the correlation between the presence of cytotoxic islet cell surface antibody and the incidence of overt diabetes in BB rats.
    Tanguay KE, Yoon JW, Hart DA.
    Diabetes Res; 1988 Aug 25; 8(4):171-5. PubMed ID: 3069281
    [Abstract] [Full Text] [Related]

  • 10. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM, Harrison DE, Moysey L, Smith D, Ashcroft SJ.
    Diabetes Res; 1985 Sep 25; 2(5):225-9. PubMed ID: 3905186
    [Abstract] [Full Text] [Related]

  • 11. Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies.
    Omar MA, Srikanta S, Eisenbarth GS.
    Diabetes Res; 1987 Apr 25; 4(4):155-7. PubMed ID: 3304781
    [Abstract] [Full Text] [Related]

  • 12. Determination of islet cell surface antibodies in first-degree relatives of type 1 diabetic patients using rat insulinoma cells.
    Ziegler B, Heinke P, Schlosser M, Rjasanowski I, Michaelis D, Ziegler M.
    Diabetes Res; 1989 Sep 25; 12(1):25-9. PubMed ID: 2698302
    [Abstract] [Full Text] [Related]

  • 13. Islet cell surface antibodies (ICSA) do bind to human pancreas: computerised, quantitative determination of ICSA using both pre- and postembedding immunocolloidal techniques.
    Kniola B, Hellström S, Ludvigsson J.
    Diabetes Res Clin Pract; 1998 Mar 25; 39(3):173-83. PubMed ID: 9649949
    [Abstract] [Full Text] [Related]

  • 14. Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity.
    Björk E, Kämpe O, Grawé J, Hallberg A, Norheim I, Karlsson FA.
    Autoimmunity; 1993 Mar 25; 16(3):181-8. PubMed ID: 8003613
    [Abstract] [Full Text] [Related]

  • 15. Lack of specificity of islet cell surface antibodies (ICSA) in IDDM.
    Peterson C, Campbell IL, Harrison LC.
    Diabetes Res Clin Pract; 1992 Jul 25; 17(1):33-42. PubMed ID: 1511659
    [Abstract] [Full Text] [Related]

  • 16. Islet cell surface antibodies preferentially inhibit glucose-stimulated insulin release in vitro.
    Kitagawa Y, Kanatsuna T, Kajiyama S, Nakamura N, Nakamura Y, Kano Y, Nakano K, Kondo M, Ludvigsson J.
    Diabetes Res Clin Pract; 1990 Apr 25; 9(1):7-13. PubMed ID: 2190782
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneous IgG subclass distribution of islet cell antibodies.
    Dozio N, Belloni C, Girardi AM, Genovese S, Sodoyez JC, Bottazzo GF, Pozza G, Bosi E.
    J Autoimmun; 1994 Feb 25; 7(1):45-53. PubMed ID: 8198701
    [Abstract] [Full Text] [Related]

  • 18. Correlations between the presence of islet cell surface antibodies in human serum and the cytotoxic effects on rat islet beta-cells.
    Jahr H, Marx S, Besch W, Ratzmann KP.
    Acta Biol Med Ger; 1982 Feb 25; 41(12):1099-1103. PubMed ID: 6765150
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneity of monoclonal antibodies against pancreatic beta cells.
    Ziegler B, Witt S, Waterstradt B, Schlosser M, Ziegler M.
    Exp Clin Endocrinol; 1989 May 25; 93(2-3):173-80. PubMed ID: 2673811
    [Abstract] [Full Text] [Related]

  • 20. Islet cell surface antibodies by an ELISA method in diabetic and nondiabetic patients.
    Betterle C, Presotto F, Magrin L, Caretto A, Pedini B, Zanchetta R.
    J Endocrinol Invest; 1991 Apr 25; 14(4):293-7. PubMed ID: 1865079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.